A85.8
|
Other specified viral encephalitis
|
B08.3
|
Erythema infectiosum [fifth disease]
|
B20
|
Human immunodeficiency virus [HIV] disease
|
B25.0
|
Cytomegaloviral pneumonitis
|
B25.1
|
Cytomegaloviral hepatitis
|
B25.2
|
Cytomegaloviral pancreatitis
|
B25.8
|
Other cytomegaloviral diseases
|
B25.9
|
Cytomegaloviral disease, unspecified
|
C88.00
|
Waldenstrom macroglobulinemia not having achieved remission
|
C90.00
|
Multiple myeloma not having achieved remission
|
C90.02
|
Multiple myeloma in relapse
|
C91.10
|
Chronic lymphocytic leukemia of B-cell type not having achieved remission
|
C91.11
|
Chronic lymphocytic leukemia of B-cell type in remission
|
C91.12
|
Chronic lymphocytic leukemia of B-cell type in relapse
|
D47.3
|
Essential (hemorrhagic) thrombocythemia
|
D55.0
|
Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency
|
D55.1
|
Anemia due to other disorders of glutathione metabolism
|
D55.21
|
Anemia due to pyruvate kinase deficiency
|
D55.29
|
Anemia due to other disorders of glycolytic enzymes
|
D55.3
|
Anemia due to disorders of nucleotide metabolism
|
D55.8
|
Other anemias due to enzyme disorders
|
D55.9
|
Anemia due to enzyme disorder, unspecified
|
D56.0
|
Alpha thalassemia
|
D56.1
|
Beta thalassemia
|
D56.2
|
Delta-beta thalassemia
|
D56.3
|
Thalassemia minor
|
D56.4
|
Hereditary persistence of fetal hemoglobin [HPFH]
|
D56.5
|
Hemoglobin E-beta thalassemia
|
D56.8
|
Other thalassemias
|
D56.9
|
Thalassemia, unspecified
|
D57.00
|
Hb-SS disease with crisis, unspecified
|
D57.01
|
Hb-SS disease with acute chest syndrome
|
D57.02
|
Hb-SS disease with splenic sequestration
|
D57.03
|
Hb-SS disease with cerebral vascular involvement
|
D57.04
|
Hb-SS disease with dactylitis
|
D57.09
|
Hb-SS disease with crisis with other specified complication
|
D57.1
|
Sickle-cell disease without crisis
|
D57.20
|
Sickle-cell/Hb-C disease without crisis
|
D57.211
|
Sickle-cell/Hb-C disease with acute chest syndrome
|
D57.212
|
Sickle-cell/Hb-C disease with splenic sequestration
|
D57.213
|
Sickle-cell/Hb-C disease with cerebral vascular involvement
|
D57.214
|
Sickle-cell/Hb-C disease with dactylitis
|
D57.218
|
Sickle-cell/Hb-C disease with crisis with other specified complication
|
D57.219
|
Sickle-cell/Hb-C disease with crisis, unspecified
|
D57.3
|
Sickle-cell trait
|
D57.414
|
Sickle-cell thalassemia, unspecified, with dactylitis
|
D57.434
|
Sickle-cell thalassemia beta zero with dactylitis
|
D57.454
|
Sickle-cell thalassemia beta plus with dactylitis
|
D57.80
|
Other sickle-cell disorders without crisis
|
D57.811
|
Other sickle-cell disorders with acute chest syndrome
|
D57.812
|
Other sickle-cell disorders with splenic sequestration
|
D57.813
|
Other sickle-cell disorders with cerebral vascular involvement
|
D57.814
|
Other sickle-cell disorders with dactylitis
|
D57.818
|
Other sickle-cell disorders with crisis with other specified complication
|
D57.819
|
Other sickle-cell disorders with crisis, unspecified
|
D58.0
|
Hereditary spherocytosis
|
D58.1
|
Hereditary elliptocytosis
|
D58.2
|
Other hemoglobinopathies
|
D58.8
|
Other specified hereditary hemolytic anemias
|
D58.9
|
Hereditary hemolytic anemia, unspecified
|
D59.0
|
Drug-induced autoimmune hemolytic anemia
|
D59.11
|
Warm autoimmune hemolytic anemia
|
D59.12
|
Cold autoimmune hemolytic anemia
|
D59.13
|
Mixed type autoimmune hemolytic anemia
|
D59.9
|
Acquired hemolytic anemia, unspecified
|
D61.01
|
Constitutional (pure) red blood cell aplasia
|
D61.02
|
Shwachman-Diamond syndrome
|
D61.810
|
Antineoplastic chemotherapy induced pancytopenia
|
D61.811
|
Other drug-induced pancytopenia
|
D61.818
|
Other pancytopenia
|
D69.0
|
Allergic purpura
|
D69.3
|
Immune thrombocytopenic purpura
|
D69.41
|
Evans syndrome
|
D69.42
|
Congenital and hereditary thrombocytopenia purpura
|
D69.49
|
Other primary thrombocytopenia
|
D80.0
|
Hereditary hypogammaglobulinemia
|
D80.1
|
Nonfamilial hypogammaglobulinemia
|
D80.2
|
Selective deficiency of immunoglobulin A [IgA]
|
D80.3
|
Selective deficiency of immunoglobulin G [IgG] subclasses
|
D80.4
|
Selective deficiency of immunoglobulin M [IgM]
|
D80.5
|
Immunodeficiency with increased immunoglobulin M [IgM]
|
D80.6
|
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia
|
D80.7
|
Transient hypogammaglobulinemia of infancy
|
D80.8
|
Other immunodeficiencies with predominantly antibody defects
|
D80.9
|
Immunodeficiency with predominantly antibody defects, unspecified
|
D81.0
|
Severe combined immunodeficiency [SCID] with reticular dysgenesis
|
D81.1
|
Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
|
D81.2
|
Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
|
D81.4
|
Nezelof's syndrome
|
D81.5
|
Purine nucleoside phosphorylase [PNP] deficiency
|
D81.6
|
Major histocompatibility complex class I deficiency
|
D81.7
|
Major histocompatibility complex class II deficiency
|
D81.82
|
Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]
|
D81.89
|
Other combined immunodeficiencies
|
D81.9
|
Combined immunodeficiency, unspecified
|
D82.0
|
Wiskott-Aldrich syndrome
|
D82.1
|
Di George's syndrome
|
D82.2
|
Immunodeficiency with short-limbed stature
|
D82.3
|
Immunodeficiency following hereditary defective response to Epstein-Barr virus
|
D82.4
|
Hyperimmunoglobulin E [IgE] syndrome
|
D82.8
|
Immunodeficiency associated with other specified major defects
|
D82.9
|
Immunodeficiency associated with major defect, unspecified
|
D83.0
|
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
|
D83.1
|
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
|
D83.2
|
Common variable immunodeficiency with autoantibodies to B- or T-cells
|
D83.8
|
Other common variable immunodeficiencies
|
D83.9
|
Common variable immunodeficiency, unspecified
|
D84.0
|
Lymphocyte function antigen-1 [LFA-1] defect
|
D84.1
|
Defects in the complement system
|
D84.9
|
Immunodeficiency, unspecified
|
D89.3
|
Immune reconstitution syndrome
|
D89.810
|
Acute graft-versus-host disease
|
D89.811
|
Chronic graft-versus-host disease
|
D89.812
|
Acute on chronic graft-versus-host disease
|
D89.813
|
Graft-versus-host disease, unspecified
|
D89.82
|
Autoimmune lymphoproliferative syndrome [ALPS]
|
D89.831
|
Cytokine release syndrome, grade 1
|
D89.832
|
Cytokine release syndrome, grade 2
|
D89.833
|
Cytokine release syndrome, grade 3
|
D89.834
|
Cytokine release syndrome, grade 4
|
D89.835
|
Cytokine release syndrome, grade 5
|
D89.839
|
Cytokine release syndrome, grade unspecified
|
D89.84
|
IgG4-related disease
|
D89.89
|
Other specified disorders involving the immune mechanism, not elsewhere classified
|
D89.9
|
Disorder involving the immune mechanism, unspecified
|
G04.81
|
Other encephalitis and encephalomyelitis
|
G11.3
|
Cerebellar ataxia with defective DNA repair
|
G13.0
|
Paraneoplastic neuromyopathy and neuropathy
|
G13.1
|
Other systemic atrophy primarily affecting central nervous system in neoplastic disease
|
G25.82
|
Stiff-man syndrome
|
G35
|
Multiple sclerosis
|
G60.3
|
Idiopathic progressive neuropathy
|
G61.0
|
Guillain-Barre syndrome
|
G61.81
|
Chronic inflammatory demyelinating polyneuritis
|
G61.82
|
Multifocal motor neuropathy
|
G61.89
|
Other inflammatory polyneuropathies
|
G62.81
|
Critical illness polyneuropathy
|
G62.89
|
Other specified polyneuropathies
|
G64
|
Other disorders of peripheral nervous system
|
G70.00
|
Myasthenia gravis without (acute) exacerbation
|
G70.01
|
Myasthenia gravis with (acute) exacerbation
|
G70.80
|
Lambert-Eaton syndrome, unspecified
|
G70.81
|
Lambert-Eaton syndrome in disease classified elsewhere
|
G70.9
|
Myoneural disorder, unspecified
|
G72.49
|
Other inflammatory and immune myopathies, not elsewhere classified
|
G72.81
|
Critical illness myopathy
|
G72.89
|
Other specified myopathies
|
G73.1
|
Lambert-Eaton syndrome in neoplastic disease
|
G73.3
|
Myasthenic syndromes in other diseases classified elsewhere
|
H54.7
|
Unspecified visual loss
|
L10.0
|
Pemphigus vulgaris
|
L10.1
|
Pemphigus vegetans
|
L10.2
|
Pemphigus foliaceous
|
L10.3
|
Brazilian pemphigus [fogo selvagem]
|
L10.4
|
Pemphigus erythematosus
|
L10.5
|
Drug-induced pemphigus
|
L10.81
|
Paraneoplastic pemphigus
|
L10.89
|
Other pemphigus
|
L10.9
|
Pemphigus, unspecified
|
L12.0
|
Bullous pemphigoid
|
L12.1
|
Cicatricial pemphigoid
|
L12.8
|
Other pemphigoid
|
L12.9
|
Pemphigoid, unspecified
|
L13.8
|
Other specified bullous disorders
|
L95.0
|
Livedoid vasculitis
|
L95.9
|
Vasculitis limited to the skin, unspecified
|
M30.3
|
Mucocutaneous lymph node syndrome [Kawasaki]
|
M33.00
|
Juvenile dermatomyositis, organ involvement unspecified
|
M33.01
|
Juvenile dermatomyositis with respiratory involvement
|
M33.02
|
Juvenile dermatomyositis with myopathy
|
M33.03
|
Juvenile dermatomyositis without myopathy
|
M33.09
|
Juvenile dermatomyositis with other organ involvement
|
M33.10
|
Other dermatomyositis, organ involvement unspecified
|
M33.11
|
Other dermatomyositis with respiratory involvement
|
M33.12
|
Other dermatomyositis with myopathy
|
M33.13
|
Other dermatomyositis without myopathy
|
M33.19
|
Other dermatomyositis with other organ involvement
|
M33.20
|
Polymyositis, organ involvement unspecified
|
M33.21
|
Polymyositis with respiratory involvement
|
M33.22
|
Polymyositis with myopathy
|
M33.29
|
Polymyositis with other organ involvement
|
M33.90
|
Dermatopolymyositis, unspecified, organ involvement unspecified
|
M33.91
|
Dermatopolymyositis, unspecified with respiratory involvement
|
M33.92
|
Dermatopolymyositis, unspecified with myopathy
|
M33.93
|
Dermatopolymyositis, unspecified without myopathy
|
M33.99
|
Dermatopolymyositis, unspecified with other organ involvement
|
M36.0
|
Dermato(poly)myositis in neoplastic disease
|
M60.80
|
Other myositis, unspecified site
|
R78.81
|
Bacteremia
|
T86.10
|
Unspecified complication of kidney transplant
|
T86.11
|
Kidney transplant rejection
|
T86.12
|
Kidney transplant failure
|
T86.13
|
Kidney transplant infection
|
T86.19
|
Other complication of kidney transplant
|
T86.21
|
Heart transplant rejection
|
T86.22
|
Heart transplant failure
|
T86.23
|
Heart transplant infection
|
T86.298
|
Other complications of heart transplant
|
T86.5
|
Complications of stem cell transplant
|
Z41.8
|
Encounter for other procedures for purposes other than remedying health state
|
Z48.21
|
Encounter for aftercare following heart transplant
|
Z48.22
|
Encounter for aftercare following kidney transplant
|
Z48.23
|
Encounter for aftercare following liver transplant
|
Z48.24
|
Encounter for aftercare following lung transplant
|
Z48.280
|
Encounter for aftercare following heart-lung transplant
|
Z48.288
|
Encounter for aftercare following multiple organ transplant
|
Z48.290
|
Encounter for aftercare following bone marrow transplant
|
Z48.298
|
Encounter for aftercare following other organ transplant
|
Z94.0
|
Kidney transplant status
|
Z94.1
|
Heart transplant status
|
Z94.81
|
Bone marrow transplant status
|
Z94.84
|
Stem cells transplant status
|